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Introduction
Triplet pregnancy with a complete hydatidiform mole
is a rare condition that has only been reported in a
handful of cases [1–12]. All of them happened in genetic
female patients, and only three of these pregnancies
resulted in live fetuses [8,11,12]. Herein, we present 
a case of a 46,XY female with gonadal dysgenesis 
who conceived a triplet pregnancy with one complete
hydatidiform mole after oocyte donation and in vitro
fertilization. With expectant management including se-
rial measurement of β-hCG, despite a later complication
of preeclampsia, delivery of two surviving fetuses was
achieved.
Case Report
A 36-year-old Taiwanese was diagnosed with ovarian
failure at the age of 16. Initially, she went to a local hos-
pital in 1986 because of primary amenorrhea and lack of
development of secondary sexual characteristics (both
breast development and pubic hair development at
Tanner stage I). Nevertheless, she had a normal uterus,
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SUMMARY
Objective: We present a case of triplet pregnancy with a complete hydatidiform mole, a condition carrying 
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Case Report: A 36-year-old patient with gonadal dysgenesis and a 46,XY karyotype successfully conceived a triplet
pregnancy after oocyte donation and in vitro fertilization. At mid-trimester, the pregnancy was seen harboring
a hydatidiform mole along with two other fetuses by ultrasound. Fetal karyotyping of both fetuses revealed normal
results. Serum human chorionic gonadotropin levels were followed up throughout the remainder of pregnancy.
At 33 weeks of gestation, preeclampsia ensued with worsening of maternal renal function and high blood pres-
sure, so cesarean section was arranged to deliver a set of two surviving twins. Prophylactic bilateral gonadectomy
was done at the same time to curtail the possibility of future malignancy development. Upon pathologic exami-
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plasia with atypia and necrosis were found, compatible with complete hydatidiform mole. The gonads showed
streaks of fibrous tissue, which resembled ovarian stroma and hilus cells, and an unremarkable tube. Maternal
serum human chorionic gonadotropin levels declined gradually to normal level at two months after delivery.
Conclusion: This is the first report of triplet pregnancy complicated with one complete hydatidiform mole and
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but the follicle stimulating hormone level was high
(61 mIU/mL). Under the impression of ovarian failure,
she was given sequential estrogen and progesterone,
which later resulted in regular menses.
She got married at age 35 and underwent in vitro fer-
tilization and embryo transfer in the same year using
donor oocytes at a local hospital. Then, she became
pregnant with triplets (two fetuses and one suspected
mole). Karyotyping of two fetuses revealed a normal
46,XY and 46,XX. At the same time, the patient’s chro-
mosome was checked, which revealed 46,XY. Polymerase
chain reaction study with primers (forward 5-TACAT-
GTTATGTGCTATGCC-3; backward 5-CACATTATAT-
AATATGTATGTTGTC-3) [13] confirmed the presence
of testicular determining sequence, SRY.
At 20 weeks of gestation, she was referred to our
institute for further prenatal care. Ultrasound revealed
two fetuses and another honeycomb-like mass, 10.73 ×
3.88 cm in size, at the posterior wall (Figure 1) with rich
vascularity, suggestive of molar tissue. A series of quan-
titative measurements of serum β-hCG level followed,
which revealed a level of 163,090 mIU/mL at 20 weeks,
rose to 196,980mIU/mL at 21 weeks and then plateaued
at 80,520 mIU/mL at 30 weeks (Figure 2). Serial sono-
graphy documented normal anatomy and appropriate
growth of both fetuses; the molar tissue remained sta-
tionary in size and echogenicity throughout the preg-
nancy. During pregnancy, gestational hypertension (160/
93 mmHg) developed at 28 weeks of gestation, and oral
medication with methyldopa was prescribed. Proteinuria
(500 mg/dL) occurred at 33 weeks of gestation, com-
pleting a diagnosis of preeclampsia. Owing to worsen-
ing of renal function with elevated blood urea nitrogen
and creatinine, hyperkalemia, and poor blood pressure
control, cesarean section was performed after a complete
course of corticosteroid to boost fetal lung maturity.
Two live babies with good Apgar scores were born, weigh-
ing 1,800 g and 1,860 g. Both neonates had uneventful
perinatal outcome and were discharged in good condi-
tion. The placenta weighed 850 g with part of it con-
taining grape-like tissue that was consistent with molar
change (Figure 3). Prophylactic gonadectomy was per-
formed at the same time during cesarean section.
Microscopically, the molar tissue revealed large and
hydropic chorionic villi with central cistern formation
and nonpolar trophoblastic hyperplasia with atypia
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Figure 2. Serial β-hCG change during pregnancy and postcesarean delivery in a triplet pregnancy with coexistence of one
hydatidiform mole.
Figure 1. Ultrasound at 20 weeks of gestation revealed two
live fetuses and one hydatidiform mole (arrowhead) that was
located at the posterior uterine wall with grape-like appearance.
Taiwan J Obstet Gynecol • September 2007 • Vol 46 • No 3278
P.C. Ko, et al
and necrosis, which were compatible with complete
hydatidiform mole. The pathology of the gonads
showed streaks of fibrous tissue, which resembled
ovarian stroma and hilus cells, and an unremarkable
tube. Maternal serum human chorionic gonadotropin
levels declined gradually to normal level at two months
after delivery.
Discussion
The incidence of coexisting mole and live fetus is esti-
mated to complicate 1 in 22,000 to 1 in 100,000 preg-
nancies [14], which may occur spontaneously or as a
consequence of assisted reproductive technology. The
incidence of a twin pregnancy with complete hydatidi-
form mole and a coexisting fetus after in vitro fertiliza-
tion and embryo transfer (IVF-ET) is not greater than
that of the general population [15]. Triplet pregnancy
with coexistence of complete hydatidiform mole is a
rarer condition, which has been reported previously in
12 cases (as summarized in the Table). To our knowl-
edge, our case is the first report of triplet pregnancy with
coexistence of complete hydatidiform mole happening
Table. Cases of triplet pregnancy consisting of a complete hydatidiform mole and two fetuses: maternal and fetal outcomes
Case Hormone therapy
Gestational age Number of 
Maternal complications
Maternal 
at delivery (wk) surviving fetuses chromosome
Sauerbrei Clomiphene 22 0 Vaginal bleeding, preeclampsia 46,XX
et al [3] at 22 weeks
Ohmichi hMG + hCG 17 0 Vaginal bleeding, persistent 46,XX
et al [4] trophoblastic tumor
Azuma hMG + hCG 19 0 Vaginal bleeding 46,XX
et al [5]
van de Geijn GIFT 24 0 Vaginal bleeding 46,XX
et al [6]
Shahabi Clomiphene 17 0 Persistent trophoblastic tumor, 46,XX
et al [7] choriocarcinoma, lung 
metastasis, hyperthyroidism
Shozu IVF-ET 15 0 Vaginal bleeding, persistent 46,XX
et al [8] trophoblastic tumor
Higashino Clomiphene + 15 0 Preeclampsia, secondary 46,XX
et al [9] FSH + hCG hyperthyroidism, persistent 
trophoblastic tumor
Amr Clomiphene + hCG 30 1 None 46,XX
et al [10]
Rajesh None 24 0 Vaginal bleeding 46,XX
et al [11]
Malhotra None 21 0 Vaginal bleeding 46,XX
et al [12]
Takagi hMG + hCG 28 2 Persistent trophoblastic tumor, 46,XX
et al [14] lung metastasis
Bovicelli IVF-ET 31 1 None 46,XX
et al [15]
Present case IVF-ET 33 2 Preeclampsia 46,XY
hMG = human menopausal gonadotropin; hCG = human chorionic gonadotropin; GIFT = gamete intrafallopian transfer; IVF-ET = in vitro fertilization and
embryo transfer.
Figure 3. Gross appearance of part of the placenta where
grape-like tissue was found, indicating a mole (arrow).
in a 46,XY female with gonadal dysgenesis. Concerning
fetal outcomes, it seems that fetal survival until term is
unlikely because of the maternal complications of the
mole itself. Among the cases, miscarriages occurred in
nine of them, two pregnancies ended up with one sur-
viving fetus, and there was only one pregnancy result-
ing in survival of both fetuses. In our case, the outcome
was excellent compared with other cases reported previ-
ously. Our case is the second report of survival in both
fetuses.
Hydatidiform molar change is the pathologic man-
ifestation of genetically abnormal conceptions, in which
an excess of paternally derived genetic material results
in abnormal fetoplacental development and placental
villous trophoblast hyperplasia. Pregnancies in which
molar change has been reported in association with a
live fetus generally represent dizygotic twin pregnan-
cies; on the other hand, partial hydatidiform molar tis-
sue usually results from triploidy. In cases of dizygotic
twin pregnancies, there is usually clear distinction, both
sonographically and pathologically, between the molar
and non-molar placenta. It has been reported that
coexistence of hydatidiform molar and excessive pla-
cental growth is associated with an increased risk of
preeclampsia, vaginal bleeding, hyperemesis gravidarum,
hyperthyroidism, premature delivery, and persistent ges-
tational trophoblastic disease [16]. Although a com-
plete hydatidiform mole incurs a higher risk of invasive
trophoblastic disease to the mother, it offers a chance
of delivering a healthy newborn infant. In contrast, partial
mole is lethal for the fetus and carries a small risk of 
a persistent trophoblastic tumor to the mother.
A recent review of 126 cases of twin pregnancies
and coexisting complete hydatidiform mole from Charing
Cross Hospital has shown a live birth rate of 25%, 
a 20% risk of persistent gestational trophoblastic dis-
ease, and a 75% rate of pregnancy loss, including
spontaneous miscarriages, stillbirths and therapeutic
termination [17]. But with triplet pregnancy and coex-
isting mole, our review saw a total of 13 cases (includ-
ing our case), most of which carrying significant risks 
to both mother and fetuses. The fetal loss rate of both
fetuses was 69.2% (9/13), while maternal complications
of vaginal bleeding occurred in 53.9% (7/13), persistent
trophoblastic tumor in 38.5% (5/13), preeclampsia in
23% (3/13) and secondary hyperthyroidism in 15.4%
(2/13) of cases. Compared with the previous report,
the risk of persistent gestational trophoblastic disease
in triplet pregnancy with coexisting complete hydatidi-
form mole is nearly two times that in twin pregnancy
with coexisting mole (38.5% vs. 20%).
Preeclampsia that is associated with hydatidiform
mole is considered to be clinically aggressive, so the
presence of the condition should be an indication for
imminent delivery. Other indications for termination
of the pregnancy include the development of intractable
vaginal bleeding, severe hyperemesis gravidarum, hyper-
thyroidism, or evidence of trophoblastic embolization.
In our case, the risk factors for development of pre-
eclampsia were nulliparity, age older than 35 years,
multifetal gestation, and hydatidiform mole; the delivery
took place at 33 weeks of gestation. The trend toward 
a lower frequency of preeclampsia in the pregnancy re-
sulting in surviving infants may suggest more benign
trophoblast lesions in this group of patients. On the
other hand, higher pre-evacuation β-hCG levels had 
a greater propensity to develop persistent gestational
trophoblastic tumor. So, it is important to follow up
on such cases with serial β-hCG and sonography, not
only during pregnancy but also after delivery, in order
to spot early signs of progression or even metastasis.
Pure gonadal dysgenesis, also known as Swyer syn-
drome, is a sex-reversal disorder resulting from embry-
onic testicular regression sequences, especially during
the first few weeks of fetal life, and may be induced by
mutations in the SRY gene. The Y chromosomal SRY
gene (sex-determining region of Y), which has been
mapped to a region 5 kb proximal to the pseudoauto-
somal boundary on the short arm of the Y chromo-
some, is required for regular male sex determination.
SRY expression initiates a network of gene activity that
transforms the undifferentiated gonad (i.e. genital ridge)
into a testis, so mutations in SRY gene result in XY sex
reversal and pure gonadal dysgenesis. Other than muta-
tions in the SRY gene, mutations in the SRY regulatory
elements or other genes involved in the sex differentia-
tion pathway can also lead to gonadal dysgenesis [18].
Although the SRY gene was tested positive in our case,
it apparently had one malfunction that led to develop-
ment of internal female genital organs (uterus and fal-
lopian tubes) without release of the müllerian inhibition
factor. Patients with both gonadal dysgenesis and 
Y-chromosome presence are at high risk of developing
gonadal tumors (gonadoblastoma and dysgerminoma),
and therefore, prophylactic removal of the gonads is
advised to preclude future malignant change. So, we
performed concomitant prophylactic gonadectomy for
our patient during cesarean delivery, and fortunately,
both gonads were free of malignancy then. The patient
was placed on hormonal therapy to induce regular
menstrual cycles in the postpartum period.
In summary, this is the first report of triplet preg-
nancy complicated with one complete hydatidiform
mole in a 46,XY female with gonadal dysgenesis. With
expectant management, the pregnancy was prolonged
for as long as 33 weeks of gestation so that both
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fetuses could have a good chance of survival. Although
preeclampsia is rarely reported in a pregnancy by a
46,XY female, its management, however, is not different
from that for a normal female. Triplet pregnancy with
coexistence of complete hydatidiform mole carries sig-
nificant risks to both mother and fetuses. During the
pregnancy, fetal karyotyping and serial serum β-hCG
follow-up is important. In addition, prophylactic go-
nadectomy and keeping a close watch for signs of pro-
gression or metastatic gestational trophoblastic disease
after delivery are mandatory.
Reference
1. Jones WB, Lauersen NH. Hydatidiform mole with coexistent
fetus. Am J Obstet Gynecol 1975;122:267–72.
2. Kwon HE, Park EJ, Kim SH, Chae HD, Won HS, Kim CH,
Kang BM. A case of twin pregnancy with complete hydatid-
iform mole and coexisting fetus following IVF-ET. J Assist
Reprod Genet 2002;19:144–8.
3. Sauerbrei EE, Salem S, Fayle B. Coexistent hydatidiform
mole and live fetus in the second trimester: an ultrasound
study. Radiol 1980;135:415–7.
4. Ohmichi M, Tasaka K, Suehara N, Miyake A, Tanizawa O.
Hydatidiform mole in a triplet pregnancy following
gonadotropin therapy. Acta Obstet Gynecol Scand 1986;65:
523–4.
5. Azuma C, Saji F, Takemura M, et al. Triplet pregnancy involv-
ing complete hydatidiform mole and two fetuses: genetic
analysis by deoxyribonucleic acid fingerprint. Am J Obstet
Gynecol 1992;166:664–7.
6. van de Geijn EJ, Yedema CA, Hemrika DJ, Schutte MF, 
ten Velden JJ. Hydatidiform mole with coexisting twin preg-
nancy after gamete intra-fallopian transfer. Hum Reprod
1992;7:568–72.
7. Shahabi S, Naome G, Cobin L, et al. Complete hydatidi-
form mole and coexisting Normal Fetuses. A report of two
cases with contrasting outcomes. J Reprod Med 1997;42:
756–60.
8. Shozu M, Akimoto K, Kasai T, Inoue M, Michikura Y.
Hydatidiform moles associated with multiple gestations
after assisted reproduction: diagnosis by analysis of DNA
fingerprint. Mol Hum Reprod 1998;4:877–80.
9. Higashino M, Harada N, Hataya I, Nishimura N, Kato M,
Niikawa N. Trizygotic pregnancy consisting of two fetuses
and a complete hydatidiform mole with dispermic androgen-
esis. Am J Med Genet 1999;82:67–9.
10. Amr MF, Fisher RA, Foskett MA, Paradinas FJ. Triplet preg-
nancy with hydatidiform mole. Int J Gynecol Cancer 2000;10:
76–81.
11. Rajesh U, Cohn MR, Foskett MA, Fisher RA, el Zaki D.
Triplet pregnancy with a coexisting complete hydatidiform
mole of monospermic origin in a spontaneous conception.
BJOG 2000;107:1439–42.
12. Malhotra N, Deka D, Takkar D, Kochar S, Goel S, 
Sharma MC. Hydatidiform mole with coexisting live fetus in
dichorionic twin gestation. Eur J Obstet Gynecol Reprod Biol
2001;94:301–3.
13. Behzadian MA, Tho SP, McDonough PG. The presence of
the testicular determining sequence, SRY, in 46,XY females
with gonadal dysgenesis (Swyer syndrome). Am J Obstet
Gynecol 1991;165:1887–90.
14. Takagi K, Unno N, Hyodo HE, et al. Complete hydatidiform
mole in a triplet pregnancy coexisting two viable fetuses:
Case report and review of the literature. J Obstet Gynaecol Res
2003;29:330–8.
15. Bovicelli L, Ghi T, Pilu G, et al. Prenatal diagnosis of a com-
plete mole coexisting with a dichorionic twin pregnancy: case
report. Hum Reprod 2004;19:1231–4.
16. Bristow RE, Shumway JB, Khouzami AN, Witter FR. Complete
hydatidiform mole and surviving coexistent twin. Obstet
Gynecol Surv 1996;51:705–9.
17. Foskett MA, Seckl MJ, Paranidas FJ. A review of 126 cases
registered at Charing Cross Hospital as twin/multiple preg-
nancies complicated by a complete hydatidiform mole
[abstract]. In: IXth World Congress on Gestational Trophoblastic
Diseases, November 1998, Jerusalem, Israel.
18. Shahid M, Dhillion VS, Jain N, et al. Two new novel point
mutations localized upstream and downstream of the HMG
box region of the SRY gene in three Indian 46,XY females with
sex reversal and gonadal tumour formation. Mol Hum Reprod
2004;10:521–6.
